Panoramic Health is built on the foundation of clinical quality. We strive for excellence at every stage of chronic kidney disease (CKD) care, providing real-time data and analytics for our nephrologists, while aligning them with the best resources and tools to provide the best treatment for their patients.
Panoramic Health’s integrated structure fosters continuous collaboration among physicians, clinical leaders, and centralized teams across 30+ aligned practices and 600+ providers.
We are focused on understanding and translating the latest evidence-based guidelines across the cardiovascular-renal-metabolic (CVRM) disease spectrum, allowing us to quickly adopt and deploy them to our partner practices and providers. By constantly measuring, monitoring, and sharing outcome data, we give providers the tools to ensure patients receive the right interventions along the entire chronic kidney care continuum.
Our nephrologist-led patient care delivery is clinically oriented and tech-enabled, helping to achieve:
All figures are estimates based on Panoramic Health data as of July 2025. Patient records are accessible via practice partnerships.
Our established interventions and patient care management playbook covers all stages of CKD to improve and promote the following:
Better patient access leads to better outcomes. As patients progress through the stages of CKD, appropriate visit cadence leads to lower hospitalizations, readmission rates, and costs for higher-risk patients.
We focus on providing kidney replacement therapy education, timely dialysis access placements, and required maturation procedures— performed before a patient begins dialysis— to ensure optimal starts.
By implementing a standardized transition pathway, we have effectively demonstrated our ability to improve optimal starts to dialysis across the platform
Non-optimal transitions are associated with more complications for patients, unnecessary hospitalizations, and an increased cost burden on the healthcare system.
Home dialysis more closely simulates and replaces natural kidney functions with more gentle treatments, leading to improved outcomes, better patient satisfaction, and fewer side effects. Patients benefit from improved health while maintaining their regular schedules.
Guideline-directed medication therapy (GDMT) is the proven treatment plan for slowing CKD progression through evidence-backed drug therapy prescriptions.
Our approach to GDMT incorporates 2024 Kidney Disease Improving Global Outcomes (KDIGO) guidelines for CKD patients with emphasis on simultaneously treating for comorbid conditions, such as diabetes and heart failure.
Our approach also prioritizes proven therapies to slow CKD progression and lower cardiovascular risk.
We actively manage care transitions to maintain continuity, strengthen provider coordination, reduce the risk of readmissions, and empower patients to manage their health effectively.
Most dialysis and advanced CKD patients want end-of-life services when the time is right.
We facilitate hospice and palliative care relationships for all interested practices and encourage patients to create advanced care plans and discuss them with their families.
Early evaluation and referral for transplant leads to better survival rates and quality of life than long-term dialysis — making it a critical priority in delivering high-quality kidney care.
We use the largest real-time CKD database to track more than one million patients, powering smarter risk stratification and personalized care. This helps providers deliver the right interventions at the right time.
Join the nation’s largest nephrology provider group.